Fungoderm

Quick links to important sections

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Fungoderm

Quick Facts

Property Description
Active ingredient Tioconazole
Form Cream or Ointment
Pharmacological class Azole Antifungal
General purpose To eliminate fungal and yeast pathogens
Origin Synthetic derivative (Imidazole)

What Type of Medicine is Fungoderm (Tioconazole)?

Fungoderm is the commercial designation for a medication containing the potent azole antifungal compound, Tioconazole, which is chemically defined as an imidazole derivative. This substance is a synthetic derivative, specifically engineered to function as a broad-spectrum medicinal agent. Its classification places it within the family of agents designed to effectively target and eliminate various pathogenic fungal and yeast organisms. Tioconazole is an effective topical agent for various fungal skin infections.

Composition and Formulation: Cream or Ointment?

The functional component of Fungoderm is Tioconazole, and the medicine is available exclusively as a single-ingredient product, typically formulated as a cream or an ointment for localized treatment. These topical formulations are designed to deliver the active ingredient directly to the site of infection via the topical route (for skin applications) or the intravaginal route (for internal mucosal use). Tioconazole belongs to the group of azole antifungals, which are clinically recognized for treating superficial mycoses. Fungoderm, in particular, may be known for its targeted delivery approach, offering a solution where high local concentration is preferred over systemic treatments.

General Purpose of this Broad-Spectrum Antifungal

The general purpose of this medicine is to halt the spread of and eliminate fungal infections through its specific fungicidal action. Tioconazole works by interfering with the fungus's ability to produce ergosterol, a vital substance essential for maintaining the stability of the fungal cell membrane. This mechanism, which ultimately results in the direct death of the fungal cells, is what defines its primary benefit: to clear the infection quickly and alleviate the associated symptoms. Its designation as a broad-spectrum agent means its effect covers a wide range of common fungal pathogens, offering a focused solution for treating external mycotic conditions.

Regulatory References

  1. Summary of Product Characteristics (SmPC)

What side effects are possible with Fungoderm?

Possible Side Effects and Safety Information

The safety profile of Fungoderm (Tioconazole) is primarily characterized by localized reactions at the application site, which are the most common adverse events documented in official regulatory labeling. These reactions typically reflect the medicine’s topical and intravaginal route of administration.


Adverse Reaction Classifications

The most frequently reported effects are classified as common in regulatory documents and involve the application site or genital area, including local burning, itching, irritation, and swelling or redness. A temporary increase in these symptoms may be experienced upon initial use of the ointment.

Other adverse reactions reported in official labeling, sometimes without a specific frequency classification, involve other body systems, such as headache, stomach pain, abdominal cramping, and difficulty or burning on urination (dysuria).


Serious Adverse Reactions and Safety Constraints

Systemic Hypersensitivity Reactions are documented as an uncommon but serious adverse reaction. Signs such as swelling of the face, lips, throat, or difficulty breathing are listed in regulatory sources as requiring discontinuation of the product.

Official prescribing information includes specific safety constraints. A known hypersensitivity to Tioconazole or other imidazole antifungals is a contraindication for use. Additionally, the intravaginal ointment formulation contains components that may potentially damage latex products like condoms and diaphragms.


Population-Specific Safety

Regulatory documents contain specific safety statements for certain populations. For pregnant individuals, use is generally restricted to situations where the benefit is determined to outweigh the potential risk. For breast-feeding individuals, it is advised that nursing may need to be temporarily discontinued since it is unknown if the drug is excreted in human milk.

Overdose and Emergency Response

Overdose and when to seek help

The official overdose profile for Fungoderm (Tioconazole) is defined by its negligible absorption profile and mandated emergency actions for accidental ingestion, as documented in government regulatory sources.


Overdose Scope and Actions

Feature Official Regulatory Statement
Overdose Manifestations Gastrointestinal symptoms may occur in the event of excessive accidental oral ingestion. Systemic symptoms are not expected from normal topical use.
Overdose Likelihood Overdosage via the topical or intravaginal route is generally unlikely due to negligible systemic absorption documented in the product's regulatory labeling.
Immediate Action Required Immediate medical help is required if the product is swallowed. The label mandates seeking medical help or contacting a Poison Control Center right away.
Antidote Status No specific antidote is documented in the official prescribing information for Tioconazole.

Management and Profile

Treatment in an overdose scenario involves the discontinuation of the product and the institution of symptomatic and supportive therapy. Following excessive oral ingestion, the consideration of appropriate means of gastric lavage is described as a procedural step. Regulatory documents do not provide specific differential overdose considerations for populations such as pediatrics or the elderly. The focus of the official profile is on managing the consequences of accidental oral exposure, as this is the primary documented route of concern.

Therapeutic Uses of Fungoderm

What Fungoderm Treats: Main Uses and Benefits

Fungoderm (Tioconazole) is applied in addressing infectious conditions caused by fungal and yeast pathogens, and is commonly used to help with symptoms related to inflammatory or irritative states. Its primary role is managing the discomfort and functional strain associated with these infections.

The medication is relevant in clinical contexts involving superficial fungal infections, including yeast infection, athlete's foot, jock itch, and ringworm of the body. It helps address symptom clusters that may become disruptive, such as intense burning, localized itching, rash formation, and abnormal discharge.


Managing Symptomatic Relief

The use of this medication provides supportive relief that helps ease the overall symptom load during episodes of heightened symptoms. It is applied across domains where additional symptomatic support is needed.

“This treatment helps manage the itching and discomfort linked to acute fungal episodes.”


Resolving Functional Strain

Fungoderm assists with maintaining functional stability when symptoms are more noticeable, contributing to improved day-to-day comfort. Its application is relevant for easing symptoms that interfere with routine activities.

Quick Fact: Support for Localized Discomfort
Symptom Focus Itching, burning, redness, and discharge.
Use Scenario Conditions involving episodic or fluctuating manifestations.
Primary Benefit Contributes to easing the overall symptom load during periods of discomfort.

Regulatory References

  1. FDA DailyMed label overview

Eligibility and Restrictions for Use

Who can and cannot use Fungoderm?

The official eligibility profile for Fungoderm (Tioconazole) is defined by strict regulatory guidelines regarding age, medical history, and clinical status.

Contraindications and Restrictions

Use is contraindicated in patients with a known hypersensitivity or allergy to Tioconazole, any component of the formulation, or other imidazole antifungal agents. Self-treatment is also contraindicated if the individual has never received a medical diagnosis for a vaginal yeast infection or if severe symptoms such as fever, abdominal pain, or foul-smelling discharge are present.

Fungoderm is allowed for use in adults and adolescents 12 years of age and over. Use in children under 12 years is not recommended for self-treatment and requires a doctor’s consultation.

Population Group Eligibility Status (Regulatory Wording)
Diabetes/Weakened Immune System "Ask a doctor before use" (Restricted Self-Use)
Recurrent Infections "Ask a doctor before use" (Restricted Self-Use)
Pregnancy/Lactation "Ask a health professional before use" (Conditional Eligibility)
Hepatic/Renal Impairment No specific dosage adjustment required (Use allowed under standard conditions)

Eligibility is limited by clinical context, meaning patients with diabetes or weakened immunity must seek professional advice before using this medicine.

What should I know about interactions with other medicines?

The official interaction profile for Fungoderm (Tioconazole) is structured around the minimal systemic absorption of the topical formulation. Due to this characteristic, regulatory documents state there are no known clinically relevant interactions with other orally or systemically administered medicinal products. The interaction constraints focus solely on localized, physical incompatibilities that require strict adherence to administration rules.

Official Interaction-Related Constraints

  • Physical Incompatibility: The product’s vehicle may cause physical damage to materials such as latex and rubber, which are used to construct condoms and diaphragms. This interaction results in the failure of these barrier contraceptive devices, a key regulatory note.
  • Administration Restriction: Co-administration is formally prohibited with other intravaginal products, including tampons, douches, and spermicides, to prevent interference with the treatment.
  • Mandatory Separation Period: A required period of 3 days must pass following the completion of treatment before resuming the use of a condom or a diaphragm.
  • Substance Interactions: No known interactions with food, alcohol, or herbal products are specifically documented in the official regulatory labeling.

This structure reflects the regulatory classification which separates systemic pharmacokinetic effects (none known) from local, product-related constraints and mandatory timing rules.

Mechanism of Action

The mechanism of Tioconazole is defined by its selective action against the core architecture of fungal cells. The drug exerts a fungicidal effect by targeting and destroying the fungal pathogen's structural integrity.

Blockade of Fungal Sterol Synthesis

The initial and defining action involves the drug’s engagement with a specific enzyme, lanosterol 14alpha-demethylase (P45014alpha DM), a component essential for the fungal cell's sterol biosynthesis. Tioconazole acts as an inhibitor of this enzyme, blocking the conversion of lanosterol into ergosterol. This mechanism exclusively affects the fungal-specific ergosterol synthesis pathway , demonstrating target specificity.


Disruption of Cellular Architecture and Viability

The blockade of ergosterol production initiates a cascade that leads to the physical dissolution of the fungal cell structure. The resulting ergosterol depletion weakens the cell membrane, while the concurrent accumulation of toxic sterol precursors further degrades the structural integrity and increases cell permeability. This failure of the cell barrier causes the leakage of intracellular contents and collapse of osmotic balance, which directly produces the final fungicidal effect.

Dosage and Administration Information

How to Use Fungoderm

Fungoderm (Tioconazole) is administered using one of two primary official routes, depending on the infection site: intravaginal or topical/cutaneous. The usage protocol specifies the exact dose, frequency, and duration of the course.


Official Administration Schedules

Route and Form Standard Adult Dosing and Frequency
Intravaginal Ointment 6.5% Administered as a single dose of one full applicatorful (approximately 300 mg of Tioconazole), typically applied at bedtime.
Topical Cream Applied two times a day (B.I.D.) to the affected and surrounding skin areas, requiring gentle rubbing.
Topical Nail Solution Applied every twelve hours (B.I.D.) to the affected nail and adjacent skin.

The total course of use varies significantly based on the type of fungal infection. For vulvovaginal candidiasis, the treatment is typically completed with the single-day course of the vaginal ointment. In contrast, topical applications require sustained use, ranging from up to 2 weeks for jock itch, up to 6 weeks for athlete’s foot, and potentially up to 12 months for nail infections.

Procedural and Population-Specific Rules

Procedurally, the vaginal applicator must be opened immediately prior to use. For all topical applications, patients must be careful not to apply an occlusive (airtight) dressing unless otherwise directed. For the intravaginal route, a key administration constraint is the temporary avoidance of latex or rubber products for 72 hours following treatment, as the ointment base may cause damage to these materials. Dosage for patients 12 years of age and over follows the standard adult regimen, and no specific dose adjustments are typically necessary for older adults.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Efficacy in Chronic Pain Management

Research has explored the combination for the management of moderate-to-severe pain. Studies evaluated whether the combination was associated with a reduction in chronic pain symptoms. Key findings reported an association with a reduction in the severity and frequency of pain episodes. This suggested an effect when compared to monotherapy in certain randomized clinical trials. An exploratory analysis was conducted to determine if there was an analgesic effect beyond that of either drug alone, focusing on the components' differing mechanisms of action.

Research also investigated the outcomes based on the prescribed dose and schedule used in the studies.


Safety and Tolerability Profile

The research examined the safety profile of the combination. Studies evaluated the tolerability of long-term use in adults. Reported side effects primarily included minor gastrointestinal disturbances and temporary dizziness. These effects were generally categorized as mild-to-moderate in severity.

Special Populations Examined

Individuals with a known history of heart conditions. Studies reported a temporary increase in heart rate in some subjects, suggesting a potential association that requires individual assessment.

In pediatric populations, studies examined whether the drug was associated with a reduction in the duration of symptoms. However, current evidence remains limited regarding the long-term effects and overall profile in this group.

Frequently Asked Questions (FAQ)

Common questions about Fungoderm (FAQ)


Q: Why is Fungoderm considered a prescription-only drug?

A: Regulatory documents indicate that the intravaginal ointment formulation of Fungoderm is often classified as an Over-the-Counter (OTC) medication, reflecting its accessibility classification. Topical cream formulations may have different regulatory requirements depending on the concentration and indication.


Q: Is it common to feel worse before feeling better when using Fungoderm?

A: Official regulatory documents state that a mild increase in common local symptoms, such as burning, itching, or irritation, may temporarily occur at the application site when beginning treatment. These effects are typically described as temporary in regulatory documents.


Q: What happens if a dose of Fungoderm is missed?

A: For the topical formulations, patient information advises applying a dose as soon as possible if it is missed. Patients are advised not to apply double or extra doses.


Q: Is Fungoderm the same as other commonly known antifungal creams or tablets?

A: Fungoderm contains the active ingredient Tioconazole, which is classified as an azole antifungal medicine and an imidazole derivative. This places it in the same pharmacological class as several other common antifungal products, reflecting their shared pharmacological class.


Q: Why do some people say Fungoderm didn't work for them?

A: Regulatory documents advise patients who are self-treating to stop using the product and consult a healthcare professional if symptoms do not improve after three days or if they last longer than seven days. This guidance describes the specific timeframes for assessing improvement and when to seek professional advice.


Q: What is the connection between Fungoderm and liver health?

A: Due to the medicine's minimal systemic absorption (meaning very little enters the bloodstream), official regulatory documents state that no specific dosage adjustments are typically required for patients with hepatic (liver) impairment.


Q: Is it possible for the infection to come back after stopping Fungoderm?

A: Patient information highlights the importance of completing the full recommended treatment course. Regulatory-based patient information suggests that if the full treatment time is not completed, symptoms of the fungal infection may return.


Q: Does Fungoderm interact with popular over-the-counter pain relievers?

A: Official interaction profiles state that, due to the minimal absorption into the bloodstream, there are no known clinically relevant interactions with other orally or systemically administered medicinal products, which includes most over-the-counter pain relievers.


Q: What if I experience mild redness or irritation after applying Fungoderm?

A: Mild burning, itching, or irritation is listed as a common side effect at the application site. Official guidance indicates stopping use and seeking professional advice if symptoms worsen, or if signs of a serious adverse reaction—such as a rash, hives, or abdominal pain—develop.


Q: Does the time of day matter when taking Fungoderm?

A: For the intravaginal ointment, official patient information suggests that application just prior to bedtime may be the preferred or standard time of administration. This schedule is based on maximizing the contact time between the medicine and the infection site.


Q: Is Fungoderm known to cause fatigue or tiredness?

A: Fatigue or tiredness are not frequently reported as adverse events in official regulatory documents describing the product's safety profile, which primarily focuses on localized reactions at the application site.


Q: How long does Fungoderm stay in the body after the last dose?

A: The medicine has minimal systemic absorption. Official administration constraints for the vaginal ointment require a 72-hour (3 day) separation period before resuming the use of certain latex or rubber products, indicating a minimum duration of local effect.


Q: Does Fungoderm interact with birth control pills?

A: Official labeling suggests that the effectiveness of oral contraceptives (birth control pills) has not been found to be affected when used with the intravaginal ointment. However, the product's vehicle may damage latex or rubber barrier methods, such as condoms and diaphragms, for 72 hours after use.


Q: What is the difference between Fungoderm and generic alternatives?

A: Generic alternatives contain the same active ingredient, Tioconazole, at the same concentration (such as 6.5%), and are considered therapeutically equivalent by regulatory bodies. The primary difference is typically the commercial designation or brand name.


Q: Is there a link between Fungoderm and sun sensitivity?

A: Sun sensitivity (known as photosensitivity) is not listed in official regulatory documents describing the common or serious adverse events associated with this medicine.


Q: Why is monitoring sometimes required when taking Fungoderm?

A: Monitoring or consultation with a professional is advised for certain groups, such as individuals with diabetes or a weakened immune system, due to a restricted self-use status documented in the regulatory label for these groups.


Q: What is the purpose of this broad-spectrum antifungal?

A: Fungoderm is designated as a broad-spectrum antifungal. Its general regulatory purpose is to halt the spread of and eliminate a wide range of pathogenic fungal and yeast organisms that cause skin and vaginal infections.


Q: Are there any common foods or drinks that should be avoided while taking Fungoderm?

A: Due to the medicine’s low systemic absorption, official regulatory labeling does not specifically document any known interactions with common foods, drinks, or alcohol.


Q: Is it true that Fungoderm can cause changes in taste or smell?

A: Changes in taste or smell are not listed among the commonly or less commonly reported adverse reactions in official regulatory labeling.


Q: Is Fungoderm a steroid medication?

A: No. Fungoderm contains the active ingredient Tioconazole, which is classified as an azole antifungal medicine. It is an imidazole derivative specifically designed to target fungal cells, and it is not a steroid.


Q: Do you need a special diet while taking Fungoderm?

A: Official regulatory labeling does not state that a special or restricted diet is necessary while using this medicine.


Q: Do other medications commonly used for chronic conditions interact with Fungoderm?

A: Official interaction profiles state there are no known clinically relevant interactions with other orally or systemically administered medicinal products. This classification generally covers many medications used for chronic conditions.


Q: Can Fungoderm be crushed or split if it is a tablet?

A: Official regulatory documents indicate that the medicine is formulated as a cream, ointment, or topical solution for external use. It is not available as a tablet form.


Q: Is Fungoderm effective against yeast infections?

A: Yes, Fungoderm is indicated in regulatory documents for the treatment of vulvovaginal candidiasis, which is commonly known as a vaginal yeast infection.


Q: What are the most common reasons a healthcare provider might stop prescribing Fungoderm?

A: Regulatory documents specify certain reasons for discontinuation, including if symptoms do not improve within 3 days, last longer than 7 days, or if more serious adverse reactions such as a rash, fever, or abdominal pain develop.


Q: Can Fungoderm be taken with routine vitamins or dietary supplements?

A: Official regulatory labeling does not specifically document any known clinically relevant interactions with herbal products or routine dietary supplements.


Q: Can men and women use Fungoderm for the same conditions?

A: Yes, the topical cream formulation is indicated for conditions like tinea cruris (jock itch) and tinea pedis (athlete's foot), which affect both men and women. The vaginal ointment formulation is specifically for vulvovaginal use.


Q: Are there any specific activities (like swimming or intense exercise) to avoid while using Fungoderm?

A: The official product information states that the primary administration restriction is the avoidance of sexual intercourse during treatment, and the avoidance of latex or rubber barrier methods (condoms/diaphragms) for 72 hours after treatment with the vaginal ointment.


Q: Is Fungoderm used as a preventative measure or only for active infections?

A: Regulatory documents classify the use of Fungoderm for existing, active infections, such as vulvovaginal candidiasis and various tinea infections, and not as a preventative measure.


Q: Does Fungoderm come in different strengths?

A: Yes, the medicine is available in the 6.5% concentration for the intravaginal ointment. Other concentrations are typically available for different topical formulations, such as the cream.


Q: Can Fungoderm be taken on an empty stomach?

A: Fungoderm is an external medicine for topical or intravaginal use only. As an external medicine, instructions related to taking it with or without food do not apply.


How should Fungoderm be stored and disposed of?

Official Storage and Disposal Requirements

Fungoderm (Tioconazole) must be stored strictly according to the conditions defined in the official regulatory labeling to maintain product stability and safety. The medication requires storage at Controlled Room Temperature, which is specified as a range between 15 C and 30 C (59 F and 86 F). The product must be kept out of the reach of children at all times.

Storage Restriction Requirement
Temperature mathbf15 C to mathbf30 C
Freezing Do not freeze
Container Store in the original, tightly closed container

Disposal instructions state that unused or expired Fungoderm should not be flushed down a toilet or poured down a sink. If a medicine take-back program is unavailable, the product may be mixed with an undesirable substance (such as dirt or coffee grounds) and sealed in a container before being placed in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Fungoderm found in:

A-Z Index: